3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
8
Leukemia, Myeloid, Acute
8
Multiple Myeloma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Hematologic Neoplasms
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hodgkin Disease
5
Waldenstrom Macroglobulinemia
4
Myeloproliferative Disorders
4
Lymphoma, Non-Hodgkin
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma
2
Leukemia, Prolymphocytic
2
Leukemia, Myelomonocytic, Chronic
2
Graft vs Host Disease
2
Burkitt Lymphoma
2
Bronchiolitis Obliterans Syndrome
2
Anemia, Aplastic
2
Urologic Neoplasms
1
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Soft Tissue Neoplasms
1
Sezary Syndrome
1
Interventions
Nivolumab
37
pembrolizumab
26
cabozantinib
26
Specimen Handling
23
Magnetic Resonance Spectroscopy
21
Ipilimumab
19
lenvatinib
13
belzutifan
13
Axitinib
13
CTLA-4 Antigen
10
Sunitinib
9
Radiosurgery
8
Biopsy
8
atezolizumab
7
fludarabine
4
avelumab
4
aldesleukin
4
Immunoglobulin G
4
Disulfides
4
zimberelimab
3
toripalimab
3
tivozanib
3
pazopanib
3
palbociclib
3
durvalumab
3
cemiplimab
3
Surveys and Questionnaires
3
Nephrectomy
3
Everolimus
3
Cyclophosphamide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Sirolimus
×
90 days
×
Clear all
No trials found.